OptiflowTM nasal high flow therapy

Proven respiratory support
 What is NHF?     Who is NHF for? 

While many terms (e.g. HFNC, high flow oxygen) describe nasal high flow therapy, one stands out. Optiflow nasal high flow therapy. 

Optiflow nasal high flow delivers respiratory support to your patients, by providing heated, humidified air and oxygen at flow rates up to 70 L/min through the unique Optiflow nasal cannula and delivered by a device such as the Airvo 2 nasal high flow system.  

Accelerate your understanding of high flow therapy 

If you’re new to high flow therapy, training others, or want a quick refresher, follow this learning plan to accelerate your knowledge.



What is nasal high flow (NHF/HFNC) therapy?  [7 key facts to help better understand it]   

1. Firstly, it’s called many things, High flow nasal cannula (HFNC), high flow therapy (HFT), high flow oxygen / therapy (HFO/T)...

2. It can deliver high levels of oxygen, but it is significantly more sophisticated than that – the higher rates of flow (independent of oxygen) confer benefits that oxygen alone cannot...

read on....

How quickly can nasal high flow work?

Evidence shows that when NHF is applied early enough (in patients who respond to therapy), you should see improvement in oxygenation, RR, and dyspnea within 15-30 mins. Monitoring should continue beyond this, of course.


Is there a bedside tool that provides an indicator of nasal high flow outcomes? [The ROX Index]

The recent addition of the ROX index, calculated from 3 data points collected at the bedside, can provide an indicator of nasal high flow (NHF) outcome in the first few hours of treatment, and beyond. 

ROX Index explained and educational tools

The ROX*index* combines three common measurements: FiO2, SpO2, and respiratory rate,...

read on...

Does nasal high flow (NHF) increase the risk of healthcare worker (HCW) infections?

This FAQ is taken from Flow Matters COVID-19 edition, updated Feb. 2022. Read the complete edition here. 

Clinical observations, investigative research, and expert opinions highlight that NHF therapy is not considered to represent an increased risk of HCW infection via contact, droplet, or airborne transmission routes.

Wilson et al. 2021 compared the effect of respiratory activity, noninvasive respiratory support, and facemasks on aerosol generation.

read on....

PM-622638_a(2020) & PM-624588_a(Jul21)

Enquire about Optiflow nasal high flow therapy
If you have an enquiry about our products, please provide the following information so a Fisher & Paykel Healthcare representative can contact you. For further details on how this information will be used, see below or go to our privacy statement.
Enter security code:*
 Security code